Chiasma, Inc. CHMA
Last Post: 05/20/2021 4:40:50 PM
Board Marks: 0
Posts Today: 0
Board Views Today: 6
We are a late-stage biopharmaceutical company focused on improving the lives of patients suffering from orphan diseases by developing and commercializing novel oral forms of therapies that are available today only by injection. Using our proprietary Transient Permeability Enhancer, or TPE, technology platform, we seek to develop oral therapies that eliminate the significant limitations and burdens generally associated with existing injectable therapies. We have completed a multinational Phase 3 clinical trial of our most advanced TPE platform-based product candidate, oral octreotide, for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Octreotide is an analog of somatostatin, a natural inhibitor of growth hormone secretion.
Read more: http://www.nasdaq.com/symbol/chma#ixzz3yOXrBzrA
Read more: http://www.nasdaq.com/symbol/chma#ixzz3yOXrBzrA
Chiasma, Inc. (NASDAQ: CHMA) Stock Message Board
Post
Subject
Author
Posted On
| 11 | $CHMA News Article - Chiasma to Present Encore | whytestocks | 05/20/2021 4:40:50 PM |
| 10 | $CHMA News Article - Chiasma Merger | whytestocks | 05/05/2021 11:55:47 AM |
| 9 | $CHMA News Article - Chiasma Reports First | whytestocks | 05/05/2021 10:15:49 AM |
| 8 | $CHMA News Article - Amryt Pharma to Acquire | whytestocks | 05/05/2021 10:10:47 AM |
| 7 | $CHMA News Article - Chiasma Announces | whytestocks | 08/17/2020 4:35:49 PM |
| 6 | CHMA 26% v19,1M c7.86 f31,7M H9ish in a few | znewcar1 | 07/23/2019 11:13:32 PM |
| 5 | $CHMA News Article - NetworkNewsBreaks - Chiasma, | whytestocks | 04/12/2019 12:15:40 PM |
| 4 | $CHMA News Article - Chiasma to Participate in | whytestocks | 03/04/2019 4:31:40 PM |
| 3 | 40% .5M C1.75 solid slope up | znewcar1 | 08/10/2018 4:15:54 PM |
| 2 | y venue ideas for the bull party after approval? | Hattlem | 04/15/2016 4:42:42 AM |
| 1 | $CHMA Took a starter here | goarmy123 | 01/26/2016 6:10:39 PM |